| Date Filed | Type | Description |
| 05/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2023 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 04/13/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
3
| Gordon Michael Adam (General Counsel) has filed a Form 3 on PAVmed Inc. |
| 04/11/2022 |
4
| MCGRATH DENNIS M (President & CFO) has filed a Form 4 on PAVmed Inc.|
Txns:
| Paid exercise price by delivering 199,973 shares
@ $1.18, valued at
$236k
|
|
| 04/11/2022 |
4
| Aklog Lishan (Chairman and CEO) has filed a Form 4 on PAVmed Inc.|
Txns:
| Paid exercise price by delivering 79,636 shares
@ $1.18, valued at
$94k
|
|
| 03/01/2022 |
4
| Baxter Timothy E (Director) has filed a Form 4 on PAVmed Inc.|
Txns:
| Granted 80,000 options to buy
@ $1.59, valued at
$127.2k
|
|
| 03/01/2022 |
4
| Baxter Timothy E (Director) has filed a Form 4 on PAVmed Inc.|
Txns:
| Granted 75,000 options to buy
@ $5.79, valued at
$434.3k
|
|
| 03/01/2022 |
3
| Baxter Timothy E (Director) has filed a Form 3 on PAVmed Inc. |
| 02/24/2022 |
4
| O'Neil Shaun (COO) has filed a Form 4 on PAVmed Inc.|
Txns:
| Paid exercise price by delivering 75,000 shares
@ $2.43, valued at
$182.3k
Granted 300,000 options to buy
@ $1.48, valued at
$444k
|
|
| 02/24/2022 |
3
| O'Neil Shaun (COO) has filed a Form 3 on PAVmed Inc. |
| 02/23/2022 |
4
| Glennon Michael J (Director) has filed a Form 4 on PAVmed Inc.|
Txns:
| Granted 80,000 options to buy
@ $1.59, valued at
$127.2k
|
|
| 02/23/2022 |
4
| DeGuzman Brian J. (Chief Medical Officer) has filed a Form 4 on PAVmed Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.59, valued at
$79.5k
|
|
| 02/23/2022 |
4
| White Debra (Director) has filed a Form 4 on PAVmed Inc.|
Txns:
| Granted 80,000 options to buy
@ $1.59, valued at
$127.2k
|
|
| 02/23/2022 |
4
| Cox James L (Director) has filed a Form 4 on PAVmed Inc.|
Txns:
| Granted 80,000 options to buy
@ $1.59, valued at
$127.2k
|
|
| 02/23/2022 |
4
| Sparks Ronald M (Director) has filed a Form 4 on PAVmed Inc.|
Txns:
| Granted 80,000 options to buy
@ $1.59, valued at
$127.2k
|
|
| 02/23/2022 |
4
| MCGRATH DENNIS M (President & CFO) has filed a Form 4 on PAVmed Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.59, valued at
$238.5k
|
|
| 02/23/2022 |
4
| Aklog Lishan (Chairman and CEO) has filed a Form 4 on PAVmed Inc.|
Txns:
| Granted 200,000 options to buy
@ $1.59, valued at
$318k
|
|
| 02/18/2022 |
4
| Harvey Joan B (Director) has filed a Form 4 on PAVmed Inc.|
Txns:
| Granted 179,350 options to buy
@ $2.05, valued at
$367.7k
|
|
| 02/18/2022 |
3
| Harvey Joan B (Director) has filed a Form 3 on PAVmed Inc. |
| 10/20/2021 |
4
| PAVmed Inc. (10% Owner) has filed a Form 4 on Lucid Diagnostics Inc.|
Txns:
| Bought 571,428 shares
@ $14, valued at
$8M
|
|
| 10/13/2021 |
3
| PAVmed Inc. (10% Owner) has filed a Form 3 on Lucid Diagnostics Inc. |
| 05/03/2021 |
4
| White Debra (Director) has filed a Form 4 on PAVmed Inc.|
Txns:
| Granted 100,000 options to buy
@ $4.81, valued at
$481k
|
|
| 05/03/2021 |
3
| White Debra (Director) has filed a Form 3 on PAVmed Inc. |
| 04/05/2021 |
4
| Battleman David S. (Director) has filed a Form 4 on PAVmed Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.44, valued at
$222k
|
|
|